Dexcom Inc (DXCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 462,800 | 396,300 | 336,400 | 280,500 | 338,000 |
| Cost of Goods | 153,500 | 149,400 | 129,900 | 111,700 | 115,200 |
| Gross Profit | 309,300 | 246,900 | 206,500 | 168,800 | 222,800 |
| Operating Expenses | 208,300 | 191,300 | 208,200 | 183,900 | 387,600 |
| Operating Income | 101,500 | 56,000 | -800 | -14,400 | -164,600 |
| Interest Expense | 15,300 | 15,100 | 15,000 | 14,900 | 8,200 |
| Other Income | 8,100 | 4,900 | 6,500 | 2,700 | -4,100 |
| Pre-tax Income | 94,300 | 45,800 | -9,300 | -26,600 | -176,900 |
| Income Tax | 1,600 | N/A | 1,200 | 300 | 2,800 |
| Net Income Continuous | 92,700 | 45,800 | -10,500 | -26,900 | -179,700 |
| Net Income | $92,700 | $45,800 | $-10,500 | $-26,900 | $-179,700 |
| EPS Basic Total Ops | 0.26 | 0.13 | -0.03 | -0.08 | -0.51 |
| EPS Basic Continuous Ops | 0.26 | 0.13 | -0.03 | -0.07 | -0.51 |
| EPS Diluted Total Ops | 0.26 | 0.13 | -0.03 | -0.08 | -0.51 |
| EPS Diluted Continuous Ops | 0.25 | 0.12 | -0.03 | -0.07 | -0.50 |
| EBITDA(a) | $115,800 | $68,900 | $10,800 | $-4,500 | $-156,000 |